study	individual	group	count	intervention	measurement_type	substance	tissue	method	label	time	time_unit	value	mean	mean_pm	mean_sd	mean_se	comments	mean_unit	value_unit
FDA1995		all	12.0	GLI1po	cumulative amount	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	urine_M1+M2_GLI1po	0.0	hr		0.0					mole	mg
FDA1995		all	12.0	GLI1po	cumulative amount	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	urine_M1+M2_GLI1po	2.0	hr		7.301401869158878e-08					mole	mg
FDA1995		all	12.0	GLI1po	cumulative amount	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	urine_M1+M2_GLI1po	4.0	hr		2.8394340602284464e-07					mole	mg
FDA1995		all	12.0	GLI1po	cumulative amount	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	urine_M1+M2_GLI1po	8.0	hr		6.192668823685844e-07					mole	mg
FDA1995		all	12.0	GLI1po	cumulative amount	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	urine_M1+M2_GLI1po	12.0	hr		7.707035306334365e-07					mole	mg
FDA1995		all	12.0	GLI1po	cumulative amount	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	urine_M1+M2_GLI1po	24.0	hr		9.572949117341626e-07					mole	mg
FDA1995		all	12.0	GLI1po	cumulative amount	glimepiride-M1+glimepiride-M2	urine	LC MS/MS	urine_M1+M2_GLI1po	48.0	hr		9.735202492211838e-07					mole	mg
